In the 2021 STEP-1 trial (1,961 adults with obesity or overweight), participants receiving semaglutide plus lifestyle intervention experienced a 14.9% mean weight loss after 68 weeks, while those on placebo lost only 2.4%
To substantiate this, validation was expanded to differential expression analysis in key brain regions to investigate the etiology of depression, and in peripheral blood samples to evaluate the potential of risk genes as biomarkers
While weaving the ketogenic diet and GLP-1 therapy together is simple, it is not totally easy
the other is at the forefront of weight loss, type 2 diabetes, and metabolic health
Metabolism and Weight Management: B12 injections can aid in weight management by supporting energy production and metabolism
Conversely, if you have diabetes, cardiovascular disease, thyroid cancer history, or take multiple medications, Found's extended intake and dietitian review provide additional safety oversight